TargetMol

CEP-28122 mesylate salt (1022958-60-6 free base)

Product Code:
 
TAR-T10759
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T10759-2mg2 mg£58.00
Quantity:
TAR-T10759-5mg5mg£72.00
Quantity:
TAR-T10759-10mg10mg£96.00
Quantity:
TAR-T10759-1mL1 mL * 10 mM (in DMSO)£100.00
Quantity:
TAR-T10759-25mg25mg£149.00
Quantity:
TAR-T10759-50mg50mg£185.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CEP-28122 mesylate salt is a highly selective orally active ALK inhibitor (IC50: 1.9 nM in an enzyme-based TRF assay).
CAS:
T10759
Formula:
C29H39ClN6O6S
Molecular Weight:
635.17
Pathway:
Tyrosine Kinase/Adaptors; Angiogenesis
Purity:
0.9919
SMILES:
COC1=C(C=CC2=C1CC[C@H](CC2)N3CCOCC3)NC4=NC=C(C(N[C@@H]5[C@@H]6C[C@H]([C@@H]5C(N)=O)C=C6)=N4)Cl.CS(=O)(O)=O
Target:
ALK

Documents

References

1. Cheng M, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2012 Mar;11(3):670-679.